Last reviewed · How we verify

ozenoxacin 1% cream

Ferrer Internacional S.A. · Phase 3 active Small molecule

ozenoxacin 1% cream is a Quinolone antibiotic Small molecule drug developed by Ferrer Internacional S.A.. It is currently in Phase 3 development for Treatment of impetigo caused by susceptible bacteria.

Ozenoxacin is a quinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV.

Ozenoxacin is a quinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV. Used for Treatment of impetigo caused by susceptible bacteria.

At a glance

Generic nameozenoxacin 1% cream
SponsorFerrer Internacional S.A.
Drug classQuinolone antibiotic
TargetDNA gyrase and topoisomerase IV
ModalitySmall molecule
Therapeutic areaDermatology
PhasePhase 3

Mechanism of action

This inhibition prevents bacterial DNA replication and transcription, ultimately leading to bacterial cell death. Ozenoxacin has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about ozenoxacin 1% cream

What is ozenoxacin 1% cream?

ozenoxacin 1% cream is a Quinolone antibiotic drug developed by Ferrer Internacional S.A., indicated for Treatment of impetigo caused by susceptible bacteria.

How does ozenoxacin 1% cream work?

Ozenoxacin is a quinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV.

What is ozenoxacin 1% cream used for?

ozenoxacin 1% cream is indicated for Treatment of impetigo caused by susceptible bacteria.

Who makes ozenoxacin 1% cream?

ozenoxacin 1% cream is developed by Ferrer Internacional S.A. (see full Ferrer Internacional S.A. pipeline at /company/ferrer-internacional-s-a).

What drug class is ozenoxacin 1% cream in?

ozenoxacin 1% cream belongs to the Quinolone antibiotic class. See all Quinolone antibiotic drugs at /class/quinolone-antibiotic.

What development phase is ozenoxacin 1% cream in?

ozenoxacin 1% cream is in Phase 3.

What are the side effects of ozenoxacin 1% cream?

Common side effects of ozenoxacin 1% cream include Skin burning sensation.

What does ozenoxacin 1% cream target?

ozenoxacin 1% cream targets DNA gyrase and topoisomerase IV and is a Quinolone antibiotic.

Related